These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2967649)

  • 1. [Xanthine compounds with anti-arteriosclerotic effect in rabbits].
    Dadej R
    Ann Acad Med Stetin; 1987; 33():139-54. PubMed ID: 2967649
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental hypolipidemic and antiatherosclerotic activity of bisanions].
    Ryzhenkov VE; Khromov-Borisov NV; Mosina IV; Indenbom ML
    Farmakol Toksikol; 1979; 42(6):632-5. PubMed ID: 499472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in pharmacotherapy of arteriosclerosis].
    Balewska K; Witanowska A
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):103-7. PubMed ID: 2216947
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
    Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh
    Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].
    Ryzhenkov VE; Chistiakova AM; Okunevich IV
    Patol Fiziol Eksp Ter; 1989; (5):16-9. PubMed ID: 2616207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypolipidemic properties of triterpenoids].
    Vasilenko IuK; Lisevitskaia LI; Frolova LM; Parfent'eva EP; Skul'te IV
    Farmakol Toksikol; 1982; 45(5):66-70. PubMed ID: 7140959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sz-488, a new drug for the treatment of atherosclerosis. Theophylline derivatives 3].
    Harsányi K; Szebeni R; Korbonits D
    Acta Pharm Hung; 1973 Sep; 43(5):235-8. PubMed ID: 4755758
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for surgical treatment and medical treatment of atherosclerosis].
    Paredero Del Bosque Martin V
    Minerva Med; 1980 Oct; 71(40):2963-7. PubMed ID: 7454082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current position in the treatment of arteriosclerosis].
    Emmrich R
    Z Alternsforsch; 1974; 28(1):31-8. PubMed ID: 4409098
    [No Abstract]   [Full Text] [Related]  

  • 12. Animal models for an integrated approach to the pharmacologic control of atherosclerosis.
    Day CE; Phillips WA; Schurr PE
    Artery; 1979 Feb; 5(2):90-109. PubMed ID: 120168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atherosclerosis, hyperlipidemia and clofibrate].
    Eisenberg S; Stein Y
    Harefuah; 1979 Jun; 96(12):677-8. PubMed ID: 520921
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L; Boeri S; Ricci G
    Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A
    Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of atromid-S (clofibrate) on egg-yolk induced atherosclerosis in rabits.
    Rema U; Madhavan M
    Indian Heart J; 1976 Apr; 28(2):121-4. PubMed ID: 1033146
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phosphatidylcholine in the control of arteriosclerosis].
    Salvioli G; Lugli R; Pradelli JM
    Clin Ter; 1984 Oct; 111(1):27-44. PubMed ID: 6238778
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of clofibrate in hypercholesterinemic rabbits and in arteriosclerotic subjects-modifications of platelet aggregation and fibrinolysis as related to lipidic fractions.
    Baldoni F; Egge H; Giarola P; Müller H; Cuttin S; Gibelli A; Zilliken F; de Nicola P
    New Istanbul Contrib Clin Sci; 1972 Dec; 10(3):135-8. PubMed ID: 4670445
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dyslipemia and atherosclerotic disease. (Classification, useful determinations and treatment)].
    Naceur MB
    Tunis Med; 1971; 49(6):368-71. PubMed ID: 5152677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.